Search


The Kids CONNECT honours the many ways our community supports us to make our research great and achieve our vision of happy healthy kids.

We are establishing an Antimicrobial Resistance (AMR) Community Reference Group (CRG) to provide community perspectives on the research activities into AMR within the Wal-yan Respiratory Research Centre and in association with the Wesfarmers Centre of Vaccines & Infectious Diseases.

Neil Dad to five biological children and five long-term foster kids. Project community member, trial participant, advocate. Of my desire

News & Events
Generous new funding to fast-track rare disease diagnosis and unlock new treatmentsResearch that screens novel genetic variants identified in disease will be fast-tracked by a funding boost, offering new hope of an early diagnosis for families of children with a rare or undiagnosed genetic disease.

News & Events
New national role for The Kids’ Executive DirectorThe Australian Government has appointed the National Health and Medical Research Council (NHMRC) Council for 2024 to 2027.

News & Events
Pioneering new treatments for leukaemia in children with Down syndromeA team of world-leading scientists has secured $5 million in funding from the Leukaemia and Lymphoma Society to advance the fight against leukaemia in children with Down syndrome.

News & Events
ORIGINS celebrates it’s 10,000th baby, reaching key recruitment milestoneAustralia’s biggest longitudinal study following the health and wellbeing of children from their conception through to childhood, has welcomed its 10,000th and final participant.

News & Events
Embrace 2024 Big Idea winner announcedA project that aims to understand and support the mental health of Australians with complex gender-affirmation experiences has received the $150,000 Embrace Big Idea Grant for 2024.

News & Events
New trial aims to reduce peanut allergy in childrenMothers eating a diet rich in peanuts while breastfeeding might be helping to reduce their baby’s risk of developing a peanut allergy – that’s the hypothesis of a new clinical trial that has been granted $2.29 million in funding by the National Health and Medical Research Council (NHMRC).